Ryan A. Wilcox
University of Michigan–Ann Arbor(US)University of Michigan(US)Michigan United(US)Michigan Medicine(US)Michigan Cancer Research Consortium(US)University of Nebraska Medical Center(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, T-cell and Retrovirus Studies, Immune Cell Function and Interaction, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → B7-H3: A costimulatory molecule for T cell activation and IFN-γ production(2001)1,013 cited
- → Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial(2018)630 cited
- → Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma(2014)529 cited
- → Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma(2019)269 cited
- → Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors(2002)260 cited
- → Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial(2019)253 cited